|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.45 TWD | +0.41% |
|
+2.30% | -8.08% |
Genovate Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 438.76 million compared to TWD 434.25 million a year ago. Net loss was TWD 12.32 million compared to net income of TWD 0.372 million a year ago.
Basic loss per share from continuing operations was TWD 0.11. Diluted loss per share from continuing operations was TWD 0.11.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.08% | 82M | |
| +33.64% | 704B | |
| +28.59% | 577B | |
| -3.27% | 348B | |
| +19.11% | 327B | |
| +4.71% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.43% | 147B |
GENOVATE BIOTECHNOLOGY CO., LTD. 
